Further analysis revealed that our population is enriched for pathogenic variants in ATM, BRCA1, and CDH1 genes and that prevalence of pathogenic variants in the CHEK2 gene is lower in the Slovenian population, when compared to GnomAD non-cancer control population. This evidence concerns the gene BRCA1 and cancer.